Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study

Title:	Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study
Authors:	Berger, Tamar^{Aff1, Aff2, Aff3, IDs00277023053062_cor1}; Shochat, Tzippy^Aff4; Aumann, Shlomzion^Aff5; Nachmias, Boaz^Aff5; Goldschmidt, Neta^Aff5; Horesh, Nurit^Aff6; Harel, Reut^{Aff7, Aff8}; Aviv, Ariel^{Aff7, Aff8}; Shmerts, Ella^Aff2; Abadi, Uri^{Aff2, Aff9}; Shimony, Shai^{Aff1, Aff2, Aff10}; Raanani, Pia^{Aff1, Aff2}; Gafter‑Gvili, Anat^{Aff1, Aff2, Aff11}; Gurion, Ronit^{Aff1, Aff2}
Source:	Annals of Hematology. 102(8):2127-2136
Database:	Springer Nature Journals